Summary by Moomoo AI
Sai Seng Pharmaceutical Holdings Limited announced on April 16, 2024 that its sole shareholder SCLN ESOP Management Limited entered into a share transaction on April 5 of the same year, selling 1,106,090 shares at a price of $0.0000 per share, with a post-transaction holding of 4,404,373 shares, representing a percentage of the company's related class securities of 0.7070 17%。 The transaction was conducted pursuant to Rule 22 of the Hong Kong Code of Companies Acquisitions and Mergers. SCLN ESOP Management Limited is owned by Maples Trustee Services (Cayman) Limited, the wholly-owned trustee of the Caisson Trust. The sale of shares is in order to satisfy the Company's share purchase incentive plan approved on 24 June 2018 and the initial public offering of the shareholder resolution adopted on 22 January 2021 under the restricted share unit scheme approved by the Company on 24 June 2018 and the shareholders' resolution on 22 January 2021 Share Award Terms.